Adding Blinatumomab to Chemotherapy May Improve Survival in Infant ALL
The combination of blinatumomab and chemotherapy appears safe and effective in infants with KMT2A-rearranged ALL, according to researchers.
Diagnosis & Disease Information
Four or More CT Scans in Childhood Linked to Increased Risk of Cancer
Exposure to 4 or more CT scans before the age of 18 is associated with an increased risk of intracranial tumors, leukemia, and lymphoma, a study suggests.
Extreme Poverty Tied to Increased Risk of Relapse for Children With ALL
Among children receiving maintenance treatment for acute lymphoblastic leukemia, those living in extreme poverty have an increased risk of relapse, a study suggests.
Menstrual Disturbances Not Being Tracked, Treated in Cancer Patients
New research suggests that some cancer patients do not have their menstrual history documented and do not receive treatment for menstrual disturbances.
Polivy Combination Therapy Approved for Previously Untreated DLBCL
Polivy plus R-CHP is approved for the first-line treatment of patients with DLBCL NOS or HGBL who have an IPI score of 2 or greater.
Risk of Early Death Higher in Older Patients With Multiple Myeloma
Multiple myeloma patients aged 70 years or older have a nearly 3-fold higher rate of early death than younger patients, new research suggests.
Cancer Risk Found to Be Higher in Asthma Patients
People with asthma are more likely to develop cancer, particularly those not using inhaled steroids, a study suggests.
Risk of Cancer After CVD Diagnosis Varies by CVD Type and Cancer Type
Cardiovascular disease (CVD), particularly atherosclerotic CVD, is associated with an increased risk of multiple cancers, research suggests.
Bispecific CAR T-Cell Therapy Has “Robust” Activity in Non-Hodgkin Lymphoma
A bispecific CAR T-cell therapy produced responses in 91% of patients with relapsed/refractory non-Hodgkin lymphoma in a phase 1 trial.
FDA Approves Omisirge for Blood Cancer Patients Undergoing Cord Blood Transplant
Omisirge is a nicotinamide-modified allogeneic hematopoietic progenitor cell therapy derived from cord blood.
- Loading...
Loading...
Next post in Hematologic Cancers
Loading... 
Loading...